Key terms
About SNN
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest SNN news
Apr 02
7:20am ET
Analysts Offer Insights on Healthcare Companies: Smith & Nephew Snats (SNN), Ocuphire Pharma (OCUP) and Vertex Pharmaceuticals (VRTX)
Apr 01
8:09am ET
Smith & Nephew introduces RENASYS EDGE NPWT System
Mar 25
8:19am ET
Smith & Nephew partners with UFC as sports medicine technology provider
Feb 28
4:00pm ET
Smith & Nephew price target raised to 1,200 GBp from 1,150 GBp at Barclays
Feb 28
3:20pm ET
Smith & Nephew price target raised to 1,300 GBp from 1,248 GBp at JPMorgan
Feb 28
8:02am ET
Smith & Nephew enters CRADA with U.S. Army Institute of Surgical Research
Feb 28
7:40am ET
Balanced Outlook: Hold Rating Justified for Smith & Nephew Amidst Growth and Market Challenges
Feb 21
7:25am ET
BTIG medical technology analyst to hold analyst/industry conference call
Feb 21
4:55am ET
BTIG medical technology analyst to hold analyst/industry conference call
Feb 15
12:57pm ET
BTIG medical technology analyst to hold analyst/industry conference call
Feb 12
8:19am ET
Smith & Nephew unveils expanded sports medicine portfolio
Jan 18
3:24pm ET
Smith & Nephew price target lowered to 1,450 GBp from 1,500 GBp at Berenberg
Jan 11
7:08am ET
Smith & Nephew announces results for its REGENETEN Bioinductive Implant
Jan 08
2:54pm ET
Smith & Nephew price target raised to 1,380 GBp from 1,360 GBp at Morgan Stanley
No recent press releases are available for SNN
SNN Financials
Key terms
Ad Feedback
SNN Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
SNN Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
